INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Indaptus Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.73+0.10 (+3.80%)
Close on Oct 19, 2026
- Market cap
- $317.04M
- P/E (TTM)
- –
- Dividend yield
- –
Indaptus Therapeutics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Market Cap | $363.75M | $166.30M |
| Enterprise Value | $352.20M | $88.19M |
| PB Ratio | 31.99 | 2.03 |
| P/TBV Ratio | 31.99 | 2.29 |
Income (trailing twelve months)
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$14.77M | -$21.40M |
| Net Income | -$15.42M | -$22.46M |
| EBITDA | -$14.77M | -$16.91M |
| EPS (Diluted) | -$7.74 | -$0.83 |
Returns
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -318.0% | -53.2% |
| Return on Assets (ROA) | -163.8% | -40.9% |
Balance sheet
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $11.55M | $61.43M |
| Net Cash (Debt) | $11.55M | $15.35M |
| Net Cash Per Share | $0.09 | $0.66 |
| Equity (Book Value) | $11.37M | $49.09M |
| Book Value Per Share | $0.09 | $1.37 |
| Tangible Book Value | $11.37M | $23.52M |
Cash flow (trailing twelve months)
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$14.70M | -$12.35M |
Efficiency
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$3.08M | -$703.34K |
| Employee Count | 5 | 74 |
Dividends and yields
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -4.24% | -23.3% |
Shares
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 133,242,000 | 58,127,000 |
| Shares Change (YoY) | 7105.4% | 10.9% |
| Shares Change (QoQ) | 17.7% | 0.54% |
| Shares Held by Institutions | 0.29% | 59.4% |
Scores
| Measure | Indaptus Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | 340.57 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Indaptus Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.